WU-106

N/A

Report date: 2025/01/26 15:44:34

Base Information

Drug NameWU-106
Drug Alias Nameintegrin alpha-4/beta-1 antagonist (University of Washington/Fred Hutch)WU-106
ClassificationBiologics
Mechanisms of ActionIntegrin alpha-4/beta-1 antagonists
TargetsIntegrin alpha-4/beta-1
Therapy Area/IndicationsAnemia, Sickle Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Washington
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of WashingtonFred Hutchinson Cancer Research Center
Inactive CompaniesN/A
Active IndicationsAnemia, Sickle Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A